Defining prognosis in the era of potent antiretroviral therapy

The ART Cohort Collaboration, which includes 19 cohort studies from Europe and North America, was established to estimate prognosis of HIV-1 infected, treatment naïve patients initiating highly active antiretroviral therapy (ART).

The first paper resulting from the collaboration was published in The Lancet on 13 July 2002. The database now includes information on over 70,000 patients.

The ART Cohort Collaboration is supported by grants from the UK Medical Research Council (MRC).

The work of the Collaboration was recently presented at the 18th Conference on Retroviruses and Opportunistic Infections (CROI), Boston February 2011. You can view the posters on the CROI website.